Beta-glucans are the primary efficacy markers in medicinal mushroom supplements. Understanding their structure, mechanism of action, and how to verify their content is essential for any brand serious about product quality.
If you're building a medicinal mushroom supplement brand, beta-glucans are the single most important concept you need to understand. They are the primary bioactive compounds responsible for the immune-modulating, anti-inflammatory, and adaptogenic effects that make medicinal mushrooms clinically relevant — and they are the key quality marker that separates a genuinely efficacious mushroom extract from an overpriced powder with minimal therapeutic value.
What Are Beta-Glucans?
Beta-glucans are polysaccharides — long-chain carbohydrate molecules — found in the cell walls of fungi, yeasts, oats, and barley. In medicinal mushrooms, they take the form of beta-1,3/1,6-glucans: a backbone of glucose units linked by beta-1,3 bonds, with branching side chains connected by beta-1,6 bonds. This specific molecular architecture is what gives mushroom beta-glucans their biological activity — it is recognized by specific receptors on immune cells (particularly Dectin-1 receptors on macrophages and dendritic cells) that trigger a cascade of immune responses.
This is a fundamentally different mechanism from simple immune stimulation. Mushroom beta-glucans are immune modulators — they enhance immune surveillance and response capacity without causing the chronic inflammation associated with immune overstimulation. This is why they are of significant interest in both preventive wellness and clinical oncology support contexts.
Beta-Glucan Content Across Species
Beta-glucan content varies significantly across mushroom species and, critically, across different extracts of the same species. This is why standardization — ensuring a guaranteed minimum beta-glucan content in every batch — is so important for product consistency and label claim accuracy.
| Mushroom Species | Typical Beta-Glucan Range | FUNGY Standardization | Primary Immune Mechanism |
|---|---|---|---|
| Agaricus Blazei | 35–45% | >40% | Beta-1,3/1,6-glucan, NK cell activation |
| Turkey Tail | 30–40% | >35% | PSK, PSP — T-cell modulation |
| Tremella | 30–38% | >35% | Glucuronoxylomannan — anti-inflammatory |
| Reishi | 25–35% | >30% | Beta-glucans + triterpenes — dual mechanism |
| Lion's Mane | 25–35% | >30% | Beta-glucans + NGF stimulation |
| Meshima | 25–35% | >30% | Hispolon + proteoglycans — anti-tumor |
| Chaga | 20–30% | >8% (+ betulinic acid) | SOD, betulinic acid — antioxidant |
| Cordyceps | 20–30% | >25% (+ cordycepin) | Cordycepin — energy + immune |
| Shiitake | 20–28% | >25% | Lentinan — macrophage activation |
| Maitake | 18–25% | >20% (+ D-fraction) | D-fraction — NK cell activation |
| King Oyster | 20–28% | >25% | Beta-glucans + ergothioneine |
The Mycelium Problem: Why Source Material Matters
One of the most significant quality issues in the mushroom supplement industry is the widespread use of mycelium-on-grain (MOG) products — particularly prevalent in the US market. In MOG production, mushroom mycelium is grown on a grain substrate (typically oats or rice), and the entire substrate is then dried and powdered without separating the mycelium from the grain. The result is a product that may contain 50–70% starch from the grain, with correspondingly low actual mushroom content.
"A product labeled '500mg Lion's Mane Extract' from a mycelium-on-grain source may contain as little as 150–200mg of actual mushroom material, with the remainder being grain starch. A fruiting body extract standardized to >30% beta-glucans delivers a known, verified dose of the active compound — regardless of what the label says about total mushroom content."
At FUNGY, all our extracts use 100% fruiting body material. The fruiting body — the visible mushroom cap and stem — contains significantly higher concentrations of beta-glucans and other bioactives than mycelium, and produces an extract with a verified, consistent potency. This is reflected in our Certificates of Analysis, which report both total polysaccharide content and verified beta-glucan content using the validated Megazyme assay method.
What This Means for Your Product Label
For B2B brands, understanding beta-glucans has direct implications for your product labeling and marketing claims. Under EU food supplement regulations, structure-function claims related to immune health are permitted for beta-glucans (specifically, the EFSA-approved claim for beta-glucans from oats and barley: 'Beta-glucans contribute to the maintenance of normal blood cholesterol levels'). For mushroom-specific beta-glucans, claims must be carefully worded to comply with EU Regulation 1924/2006 on nutrition and health claims. Our regulatory team can advise on compliant claim language for your specific product and target market.
The practical takeaway is this: when evaluating mushroom extracts for your product, always request a Certificate of Analysis that reports verified beta-glucan content using a validated analytical method. Total polysaccharide content is not a reliable proxy for beta-glucan content. If a supplier cannot provide this, look elsewhere. The quality of your extract is the foundation of your product's efficacy — and your brand's reputation.
Ready to Start Your Mushroom Product Line?
Contact our B2B team to request samples, discuss formulations, or get a manufacturing quote.
